Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Debt / NOTE 0.750%10/1
-
Unit price / market price
-
$1.29
-
Total 13F principal
-
$363,935,000
-
Principal change
-
+$6,352,168
-
Total reported value
-
$473,515,000
-
Number of holders
-
53
-
Value change
-
-$1,588,875
-
Number of buys
-
20
-
Number of sells
-
25
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 as of Q3 2015
As of 30 Sep 2015 BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 had 53 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $363,935,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included ADVENT CAPITAL MANAGEMENT /DE/, Allianz Asset Management AG, CITADEL ADVISORS LLC, MACKAY SHIELDS LLC, CSS LLC/IL, SHENKMAN CAPITAL MANAGEMENT INC, BlackRock Advisors LLC, SYMPHONY ASSET MANAGEMENT LLC, Invesco Ltd., and BAKER BROS. ADVISORS LP.
This table shows 53 bond principal holders of the security as of 30 Sep 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.